Others

Product #

Image

Description

Biochem/physiol Actions

Add to Cart
M0896 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride powder Dopaminergic neurotoxin.
    • M103 1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride solid Dopaminergic neurotoxin that is more toxic in mice than MPTP.
    • 850217 3,4-Dihydroxyphenylacetic acid 98%  
    • D9378 3,4-Dihydroxy-D-phenylalanine powder, ≥98% DOPA enantiomer that lacks biological activity.
    • D9503 3,4-Dihydroxy-DL-phenylalanine Immediate precursor of dopamine; product of tyrosine hydroxylase
    • D9628 3,4-Dihydroxy-L-phenylalanine ≥98% (TLC) Natural isomer of the immediate precursor of dopamine; product of tyrosine hydroxylase
    • H3132 3-Hydroxy-4-methoxyphenethylamine hydrochloride Dopamine metabolite.
    • M4251 3-Methoxytyramine hydrochloride ≥95.5%, crystalline Major metabolite of dopamine; product of catechol O-methyltransferase.
    • C156 D-CPT tartrate >94%, solid Binds to the cocaine receptor site on the dopamine transporter and blocks dopamine uptake.
    • 855456 D-Tyrosine ReagentPlus®, 99%  
    • D1507 L-3,4-Dihydroxyphenylalanine methyl ester hydrochloride solid Precursor to L-DOPA that crosses the blood-brain barrier; antiparkinsonian agent.
    • T2269 L-Tyrosine disodium salt hydrate ≥98% (TLC), powder  
    • T2006 L-Tyrosine hydrochloride ≥98% (TLC)  
    • T3754 L-Tyrosine reagent grade, ≥98% (HPLC)  
    • A1260 Amantadine hydrochloride Dopamine releaser used to treat Parkinsonism and drug-induced extrapyramidal reactions.
    • D4446   Dopamine D1 Receptor human recombinant, expressed in HEK 293 cells, membrane suspension Membranes are suspended in 50 mM TRIS-HCl containing 10 mM MgCl2, 1.5 mM CaCl2, 1mM EDTA, 5 mM KCl, 10% glycerol, (pH 7.4 at 25 °C).
    • H1252 Homovanillic acid Fluorimetric reagent Metabolite of dihydroxyphenylacetic acid (DOPAC) by catechol O-methyltransferase; reagent for the fluorimetric determination of glucose oxidase and other oxidative enzymes
    • SML0091 L-Dopa ethyl ester ≥98% (HPLC) L-Dopa ethyl ester is a prodrug of levodopa that has greater gastric solubility. The drug is rapidly hydrolyzed to levodopa by nonspecific esterases in the gastrointestinal tract. L-Dopa ethyl ester (etilevodopa)-carbidopa treatment was well tolerated but did not demonstrate better efficacy compared with standard levodopa-carbidopa treatment. L-Dopa ethyl ester should have a significant brain penetration following an administration by injection.
    • D048 MPP+ iodide ≥98% (HPLC), solid MPP+ iodide is an active metabolite of dopaminergic neurotoxin MPTP.
    • M3690 N-Methyl-(R)-salsolinol hydrobromide ≥95% (HPLC), solid Endogenous neurotoxin in dopaminergic neurons.
    • P138 PPHT-fluorescein acetate solid  
    • P0099 Paliperidone ≥98% (HPLC), solid Paliperidone is an atypical antipsychotic; active metabolite of risperidone.
    • R0875 Reserpine Inhibits vesicular uptake of catecholamines and serotonin.
    • R9157 Ro 4-1284 ≥98% (HPLC) Ro 4-1284 is a reversible VMAT2 inhibitor.
    • D204 S-(+)-O-Desmethylraclopride hydrobromide solid, ≥98% (HPLC)  
    • S4326 SB-277011-A hydrochloride hydrate ≥98% (HPLC) SB-277011-A is a potent, selective brain-penetrant D3 dopamine receptor antagonist; 80-100x selective for D3 over D2; pKi = 7.95 for hD3 receptor.
    • T2952 Tetrabenazine ≥98% (HPLC), solid Tetrabenazine is a reversible type 2 vesicular monoamine transporter (VMAT) inhibitor. It depletes dopamine stores.